🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 9 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/12/2016 | 1,38 | 1,40 | 1,34 | 1,37 | -0,72% | 4,35% | 1.253.200 |
| 06/12/2016 | 1,41 | 1,44 | 1,35 | 1,38 | -2,82% | 6,38% | 1.878.400 |
| 05/12/2016 | 1,40 | 1,45 | 1,39 | 1,42 | -1,39% | 4,29% | 2.399.100 |
| 02/12/2016 | 1,40 | 1,48 | 1,33 | 1,44 | +9,09% | 10,71% | 6.306.200 |
| 01/12/2016 | 1,50 | 1,53 | 1,32 | 1,32 | -8,33% | 14,00% | 5.629.200 |
| 30/11/2016 | 1,69 | 1,80 | 1,42 | 1,44 | -67,20% | 22,49% | 18.139.900 |
| 29/11/2016 | 4,46 | 4,50 | 4,37 | 4,39 | -1,57% | 2,91% | 3.039.300 |
| 28/11/2016 | 4,67 | 4,67 | 4,41 | 4,46 | -4,50% | 5,57% | 1.394.100 |
| 25/11/2016 | 4,46 | 4,70 | 4,40 | 4,67 | +4,01% | 6,73% | 571.300 |
| 23/11/2016 | 4,49 | 4,55 | 4,25 | 4,49 | +1,13% | 6,68% | 1.711.700 |
| 22/11/2016 | 4,39 | 4,56 | 4,37 | 4,44 | +2,07% | 4,33% | 1.891.200 |
| 21/11/2016 | 4,44 | 4,47 | 4,22 | 4,35 | -1,58% | 5,63% | 1.303.300 |
| 18/11/2016 | 4,55 | 4,61 | 4,40 | 4,42 | -2,00% | 4,62% | 879.800 |
| 17/11/2016 | 4,45 | 4,59 | 4,39 | 4,51 | +1,58% | 4,58% | 689.000 |
| 16/11/2016 | 4,73 | 5,01 | 4,40 | 4,44 | -6,13% | 12,90% | 1.608.800 |
| 15/11/2016 | 4,44 | 4,77 | 4,38 | 4,73 | +7,01% | 8,78% | 985.700 |
| 14/11/2016 | 4,25 | 4,56 | 4,25 | 4,42 | +5,74% | 7,18% | 1.885.500 |
| 11/11/2016 | 4,40 | 4,56 | 4,14 | 4,18 | -2,79% | 9,55% | 2.415.300 |
| 10/11/2016 | 4,24 | 4,35 | 4,09 | 4,30 | +2,38% | 6,01% | 2.321.200 |
| 09/11/2016 | 4,82 | 5,50 | 4,15 | 4,20 | -31,26% | 28,01% | 6.462.800 |
| 08/11/2016 | 5,82 | 6,18 | 5,82 | 6,11 | +4,09% | 6,19% | 765.500 |
| 07/11/2016 | 5,78 | 6,04 | 5,68 | 5,87 | +3,35% | 6,23% | 714.400 |
| 04/11/2016 | 5,55 | 5,75 | 5,55 | 5,68 | +1,70% | 3,60% | 612.000 |
| 03/11/2016 | 5,89 | 5,90 | 5,56 | 5,59 | -4,37% | 5,77% | 756.200 |
| 02/11/2016 | 6,03 | 6,06 | 5,83 | 5,84 | -2,99% | 3,81% | 590.200 |
| 01/11/2016 | 5,80 | 6,04 | 5,77 | 6,02 | +3,79% | 4,66% | 590.800 |
| 31/10/2016 | 5,83 | 5,93 | 5,64 | 5,80 | -1,11% | 4,92% | 471.900 |
| 28/10/2016 | 6,00 | 6,08 | 5,80 | 5,87 | -2,90% | 4,67% | 625.900 |
| 27/10/2016 | 6,15 | 6,28 | 6,00 | 6,04 | -1,79% | 4,55% | 452.100 |
| 26/10/2016 | 6,28 | 6,44 | 6,13 | 6,15 | -2,84% | 4,86% | 480.900 |